Secondary Logo

Institutional members access full text with Ovid®


Goniotomy Using the Kahook Dual Blade in Severe and Refractory Glaucoma

6-Month Outcomes

Salinas, Lauriane, MD*,†; Chaudhary, Ankita, MD*; Berdahl, John P., MD; Lazcano-Gomez, Gabriel S., MD§; Williamson, Blake K., MD, MPH, MS; Dorairaj, Syril K., MD; Seibold, Leonard K., MD#; Smith, Sanjay, MD**; Aref, Ahmad A., MD††; Darlington, Jason K., MD‡‡; Jimenez-Roman, Jesus, MD§§; Mahootchi, Ahad, MD∥∥; Boucekine, Mohamed, PhD¶¶; Mansouri, Kaweh, MD, MPH*,##

doi: 10.1097/IJG.0000000000001211
Online Articles: Letters to the Editor

*Glaucoma Research Center, Montchoisi Clinic, Swiss Vision Network, Lausanne Switzerland

Department of Ophthalmology North University Hospital Center

¶¶Aix-Marseille University EA 3279 - Chronic Diseases and Quality of Life, Research Unit and Department of Public Health Marseille, France

Vance Thompson Vision, Sioux Falls, SD

§Asociacion para Evitar la Ceguera

§§Hospital Dr. Luis Sanchez Bulnes Mexico City, Mexico

Williamson Eye Center, Baton Rouge, LA

Mayo Clinic, Jacksonville

**Medical Eye Associates, South Miami

‡‡Eye Institute, Melbourne

∥∥The Eye Clinic of Florida, Zephyrhills, FL

#University of Colorado School of Medecine, Aurora

##Department of Ophthalmology University of Colorado School of Medicine Denver, CO

††University of Illinois, Chicago, IL

Supported in part by the Swiss Glaucoma Research Foundation, Lausanne, Switzerland.

Disclosure: K.M.: Santen (C), Sensimed (C), Topcon (S), Alcon (S), Allergan (S), Optovue (S); ImplanData (C); A.M.: Iridex, Imprimis Pharma, New World Medical, Valeant, Ellex (C, S); A.A.: NWM (C); B.K.W.: Alcon, Allergan, Glaukos, NWM, Sight Sciences (C, S); L.K.S.: Allergan, Sensimed, NWM (C); J.P.B.: Alcon, Allergan, Glaukos, NWM (C); S.K.D., J.K.D., G.S.L., J.J.: NWM (C). The remaining authors declare no conflict of interest.

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.